文献速递肿瘤 PET/CT放射性药物与辐射防护

基于骨图谱与截断校正的改进衰减校正对全身PET/MR定量影响的评估

Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-11-09

本研究纳入51例肿瘤患者行全身PET/MR,比较标准四分区、五分区(加骨图谱)、四分区+HUGE截断校正、五分区+HUGE四种μmap重建对99个病灶SUVmax的影响。加骨后SUVmax平均增加1.4%±2.5%,加HUGE后增加2.1%±3.5%,两者同时加后增加4.4%±5.7%,单个病灶最大偏差达35%。作者认为该新型衰减校正方法改善了PET定量,重建时间短、流程简便、质量稳健,支持进一步常规临床应用。

要点

  • 在四分区μmap基础上加骨图谱后,99个病灶平均SUVmax增加1.4%±2.5%。
  • 加HUGE截断校正后平均SUVmax增加2.1%±3.5%,骨+HUGE同时加后增加4.4%±5.7%。
  • 单个病灶因身体位置不同,加骨与截断校正后定量偏差最大可达35%。

核心结论

  • 作者认为,同时具有骨模型与截断校正的新型衰减校正方法改善了全身PET/MR的PET定量。
  • 作者指出该方法重建时间短、重建流程简便、衰减校正质量稳健,支持其进一步常规临床应用。

研究设计与样本

  • 本研究纳入51例肿瘤患者,全部接受全身PET/MR检查。
  • 以MR-based Dixon法提供的四分区μmap(背景空气、肺、脂肪、软组织)作为PET/MR衰减校正的参考。
  • 模型化骨图谱提供骨组织作为第五分区,HUGE方法提供截断校正。
  • 每个全身PET数据集分别用四分区μmap、五分区μmap、四分区μmap+HUGE、五分区μmap+HUGE重建四次。
  • 测量每个病灶的SUVmax以评估各μmap对PET定量的影响。

主要发现

  • 每位患者的全部四种μmap在衰减校正PET数据重建中均给出稳健结果。
  • 共对99个肿瘤和病灶进行SUVmax定量。
  • 与参考四分区μmap相比,加骨后全部99个病灶的平均SUVmax增加1.4%±2.5%。
  • 与参考四分区μmap相比,加HUGE后平均SUVmax增加2.1%±3.5%,加骨+HUGE后增加4.4%±5.7%。
  • 加骨与截断校正后,单个病灶因身体位置不同,定量偏差最大可达35%。

临床怎么用

  • 作者认为,同时具有骨模型与截断校正的新型衰减校正方法改善了全身PET/MR的PET定量,并支持其进一步常规临床应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recent studies have shown an excellent correlation between PET/MR and PET/CT hybrid imaging in detecting lesions. However, a systematic underestimation of PET quantification in PET/MR has been observed. This is attributable to two methodological challenges of MR-based attenuation correction (AC): (1) lack of bone information, and (2) truncation of the MR-based AC maps (μmaps) along the patient arms. The aim of this study was to evaluate the impact of improved AC featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR. METHODS: The MR-based Dixon method provides four-compartment μmaps (background air, lungs, fat, soft tissue) which served as a reference for PET/MR AC in this study. A model-based bone atlas provided bone tissue as a fifth compartment, while the HUGE method provided truncation correction. The study population comprised 51 patients with oncological diseases, all of whom underwent a whole-body PET/MR examination. Each whole-body PET dataset was reconstructed four times using standard four-compartment μmaps, five-compartment μmaps, four-compartment μmaps + HUGE, and five-compartment μmaps + HUGE. The SUVmax for each lesion was measured to assess the impact of each μmap on PET quantification. RESULTS: All four μmaps in each patient provided robust results for reconstruction of the AC PET data. Overall, SUVmax was quantified in 99 tumours and lesions. Compared to the reference four-compartment μmap, the mean SUVmax of all 99 lesions increased by 1.4 ± 2.5% when bone was added, by 2.1 ± 3.5% when HUGE was added, and by 4.4 ± 5.7% when bone + HUGE was added. Larger quantification bias of up to 35% was found for single lesions when bone and truncation correction were added to the μmaps, depending on their individual location in the body. CONCLUSION: The novel AC method, featuring a bone model and truncation correction, improved PET quantification in whole-body PET/MR imaging. Short reconstruction times, straightforward reconstruction workflow, and robust AC quality justify further routine clinical application of this method.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Oehmigen M, Lindemann ME, Gratz M, et al. Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR. Eur J Nucl Med Mol Imaging. 2017. PMID: 29119237. doi:10.1007/s00259-017-3864-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。